TAR POMADE

Preparatomtale

                                PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Tar Pomade
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Coal tar solution
6.0% w/w
Salicylic Acid
2.0% w/w
3 PHARMACEUTICAL FORM
Light brown coloured ointment.
4 CLINICAL PARTICULARS 
4.1 THERAPEUTIC INDICATIONS
It is recommended for use in the treatment of eczema,
psoriasis and related skin affections.
4.2 POSOLOGY AND METHOD OF ADMINSTRATION
_Dosage_
Apply to the affected area as directed
by the pharmacist and/or the physician.
_Administration_
Cutaneous (topical) use.
4.3 CONTRAINDICATIONS
Use in persons hypersensitive to any of the ingredients.
4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE
If the condition does not improve, or is aggravated
consult the doctor.
Exposure of the treated areas to direct sunlight should
be avoided after application.
Avoid contact with eyes.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION 
No interactions known.
4.6 PREGNANCY AND LACTATION
Use in pregnancy and lactation has not been established
for this product, however, due to the established
nature of the 
ingredients, no adverse effects are anticipated.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Issued 15/11/2005_
_CRN 2016847_
_page number: 1_
4.7 EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
None.
4.8 UNDESIRABLE EFFECTS
None.
4.9 OVERDOSE
Not applicable.
5 PHARMACOLOGICAL PROPERTIES
5.1 PHARMACODYNAMIC PROPERTIES
Tar pomade has antipruritic, keratolytic and
antiseptic properties.
5.2 PHARMACOKINETIC PROPERTIES
Not relevant.
5.3 PRECLINICAL SAFETY DATA
Coal Tar
Skin and eye irritation:
Skin (human): 15 µg/3D-1
Mild
Skin (rabbit):
5%/3H
Mild
Salicylic Acid
Skin and eye irritation:
Skin (rabbit)
500 mg/24H
Mild
Eye (rabbit)
100 mg Severe
Skin (man):
TDLo: 57 mg/kg Sense organs�
                                
                                read_full_document